CBD Life Sciences Inc.
CBDL
$0.0004
$0.000.00%
| 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | |
|---|---|---|---|---|---|
| Net Income | 28.29% | 78.62% | 0.00% | 38.63% | -23.83% |
| Total Depreciation and Amortization | 17.24% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -51.40% | -26.67% | 0.00% | -118.45% | 33.55% |
| Cash from Operations | 15.65% | 76.13% | 0.00% | 37.14% | -22.83% |
| Capital Expenditure | -- | -331.25% | 0.00% | 94.10% | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00% | 53.37% | -100.00% |
| Cash from Investing | -- | -112.96% | 0.00% | 89.43% | -99.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00% | -35.77% | 24.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 0.00% | -28.58% | 11.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.69% | -230.20% | 0.00% | 9,061.29% | -101.35% |
